| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/18/2022 | Metacrine, Inc. | MTCR | Grant | Stock Option (right to buy) | 16.5k | $0.42 | $6.9k | | 05/18/2022 |
| 05/24/2021 | Metacrine, Inc. | MTCR | Grant | Stock Option (right to buy) | 16.5k | $4.07 | $67.2k | | 05/24/2021 |
| 03/17/2021 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 24k | $2.29 | $55k | | 03/17/2021 |
| 05/25/2020 | Tempest Therapeutics, Inc. | OVAS | Grant | Stock Option (right to buy) | 282k | $2.00 | $564k | | 05/25/2020 |
| 06/20/2019 | Tempest Therapeutics, Inc. | OVAS | Grant | Employee Stock Option (right to buy) | 76k | $11.59 | $880.9k | | 06/20/2019 |
| 01/15/2019 | Tempest Therapeutics, Inc. | OVAS | Grant | Employee Stock Option (right to buy) | 174k | $8.80 | $1.5M | | 01/15/2019 |
| 12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Employee Stock Option (right to buy) | 174.8k | $16.40 | $2.9M | | 12/07/2018 |
| 12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Employee Stock Option (right to buy) | 151.6k | $4.44 | $673.1k | | 12/07/2018 |
| 12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Employee Stock Option (right to buy) | 60.2k | $1.08 | $65k | | 12/07/2018 |
| 12/07/2018 | Tempest Therapeutics, Inc. | OVAS | Grant | Common Stock | 74.4k | $0.00 | $0 | | 12/07/2018 |